Page 4 - HFA Annual Report 2013
P. 4
Financial position 2013 Financial Highlights
ASSetS ReVenue
cash and equivalents $707,968.48 Donations & Memorials 0.66% $13,736.22
receivables $332,474.69 general Funding 1.66% $34,790.00
other $47,198.42 Membership 1.95% $40,900.00
Furniture & Fixtures $18,575.50 special events 1.88% $39,368.00
grants 39.35% $823,580.08
totAl ASSetS $1,106,217.09
government grants 25.95% $543,031.35
Publications 3.87% $81,000.00
lIABIlItIeS symposium 24.65% $515,800.00
Accounts Payable $76,683.81 interest income 0.03% $609.32
other Liabilities $303,117.33
totAl ReVenue 100.0% $2,092,796.97
totAl lIABIlItIeS $379,801.14
eXpenSeS (By Class)
net ASSetS symposiums 23.96% $504,005.46
net Assets $740,434.09 Blood Brotherhood 18.85% $396,533.87
net income $14,019.00 Blood sisterhood 1.58% $39,743.55
outreach 10.60% $222,999.92
totAl net ASSetS $726,415.09
choice 9.14% $192,222.59
helping hands 7.07% $148,724.78
totAl lIABIlItIeS & net ASSetS $1,106,216.23 FitFactor 9.20% $193,463.43
Dads in Action 9.11% $191,518.78
Administrative 3.12% $65,677.25
Publications 5.11% $107,381.67
Fundraising 2.27% $47,665.23
*The financial statements of Hemophilia Federation are audited by the accounting firm Winter,
Kloman, Moter & Repp, S.C. Complete audited financial statements for Hemophilia Federation of totAl eXpenSeS 100.0% $2,103,343.42
America can be obtained by request from: www.hemophiliafed.org or sending a request to
820 First Street NE, Suite 720 Washington DC 20002 or by calling 202.675.6984.
DID You Know?
hemophilia is very rare… only 20,000 Americans have the disorder.
Currently, there is no cure.
treatment for individuals with severe hemophilia can be very costly,
exceeding annual costs of $300,000.
spontaneous bleeding, inhibitors, surgeries, or treatment for co-infections will increase the costs exponentially.
ASSetS ReVenue
cash and equivalents $707,968.48 Donations & Memorials 0.66% $13,736.22
receivables $332,474.69 general Funding 1.66% $34,790.00
other $47,198.42 Membership 1.95% $40,900.00
Furniture & Fixtures $18,575.50 special events 1.88% $39,368.00
grants 39.35% $823,580.08
totAl ASSetS $1,106,217.09
government grants 25.95% $543,031.35
Publications 3.87% $81,000.00
lIABIlItIeS symposium 24.65% $515,800.00
Accounts Payable $76,683.81 interest income 0.03% $609.32
other Liabilities $303,117.33
totAl ReVenue 100.0% $2,092,796.97
totAl lIABIlItIeS $379,801.14
eXpenSeS (By Class)
net ASSetS symposiums 23.96% $504,005.46
net Assets $740,434.09 Blood Brotherhood 18.85% $396,533.87
net income $14,019.00 Blood sisterhood 1.58% $39,743.55
outreach 10.60% $222,999.92
totAl net ASSetS $726,415.09
choice 9.14% $192,222.59
helping hands 7.07% $148,724.78
totAl lIABIlItIeS & net ASSetS $1,106,216.23 FitFactor 9.20% $193,463.43
Dads in Action 9.11% $191,518.78
Administrative 3.12% $65,677.25
Publications 5.11% $107,381.67
Fundraising 2.27% $47,665.23
*The financial statements of Hemophilia Federation are audited by the accounting firm Winter,
Kloman, Moter & Repp, S.C. Complete audited financial statements for Hemophilia Federation of totAl eXpenSeS 100.0% $2,103,343.42
America can be obtained by request from: www.hemophiliafed.org or sending a request to
820 First Street NE, Suite 720 Washington DC 20002 or by calling 202.675.6984.
DID You Know?
hemophilia is very rare… only 20,000 Americans have the disorder.
Currently, there is no cure.
treatment for individuals with severe hemophilia can be very costly,
exceeding annual costs of $300,000.
spontaneous bleeding, inhibitors, surgeries, or treatment for co-infections will increase the costs exponentially.
